ClinicalTrials.gg
CompletedNCT07928557Updated Nov 10, 2026

THE EFFECTS OF TAI CHI IN INDIVIDUALS WITH MULTIPLE SCLEROSIS

An interventional study of Tai Chi Exercises Program and Frenkel Home Exercises in Multiple Sclerosis, sponsored by Pamukkale University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 1 month after the study started (first participant enrolled Oct 2023, registered Nov 2026).
Updated Nov 10, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
20 Years to 60 Years
Sex
All
01

Study summary

This study aimed to evaluate the effects of Tai Chi exercise on cognitive functions, fatigue, and depressive symptoms in individuals with Multiple Sclerosis (MS). MS is a chronic neurological disease characterized by demyelination within the central nervous system and is frequently associated with cognitive, physical, and psychological impairments.

Individuals diagnosed with MS were assigned to either an 8-week Tai Chi exercise program or a home-based Frenkel exercise program. Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R). Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The study aimed to investigate the effects of Tai Chi exercise compared with a home-based exercise program on cognitive performance, fatigue, and depressive symptoms in individuals with MS. The findings may contribute to the evidence base for non-pharmacological rehabilitation approaches in MS management.

Read the detailed description

Multiple Sclerosis (MS) is a chronic, immune-mediated neurological disease characterized by inflammation, demyelination, and neurodegeneration within the central nervous system. Cognitive impairment, fatigue, and depression are among the most common and disabling symptoms in individuals with MS, significantly affecting their quality of life. In addition to pharmacological treatments, exercise-based rehabilitation approaches have gained increasing attention in recent years.

This randomized controlled study investigated the effects of a structured Tai Chi exercise program on cognitive functions, fatigue, and depressive symptoms in individuals with MS. Participants diagnosed with MS were randomly allocated to either a Tai Chi intervention group or an active control group receiving a home-based Frenkel exercise program. Both groups continued their standard medical care throughout the study.

The Tai Chi intervention was conducted over 8 weeks, with two supervised sessions per week. Each session lasted approximately 50 minutes and included warm-up exercises, Tai Chi practice, and cool-down activities.

Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which comprises three tests: the Symbol Digit Modalities Test (SDMT), assessing information processing speed; the California Verbal Learning Test-II (CVLT-II), assessing verbal learning and memory; and the Brief Visuospatial Memory Test-Revised (BVMT-R), assessing visuospatial learning and memory. Fatigue was evaluated using the Fatigue Impact Scale (FIS), while depressive symptoms were assessed using the Beck Depression Inventory (BDI).

The primary outcome was cognitive performance following the intervention, while secondary outcomes included changes in fatigue and depressive symptoms. All outcome measures were assessed at baseline and after the 8-week intervention period.

This study aimed to contribute to the evidence regarding the potential role of Tai Chi as a non-pharmacological rehabilitation approach for managing cognitive and psychological symptoms in individuals with MS.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • multiple sclerosis
  • tai chi
  • executive function
  • cognitive rehabilitation
  • fatigue
  • depression
  • relapsing remitting multiple sclerosis
03

In context

Multiple Sclerosis

3,264 studies on the registry are indexed under Multiple Sclerosis; 659 are open to participants now.

This study's enrollment of 44 is below the median of 50 across 2,201 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Pamukkale University is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Diagnosis of multiple sclerosis (MS) according to the McDonald criteria.
  2. Relapsing-remitting multiple sclerosis (RRMS) phenotype.
  3. Age between 20 and 60 years.
  4. Willingness to participate in the study.
  5. Expanded Disability Status Scale (EDSS) score ≤3.5.

Exclusion criteria

Exclusion Criteria:

  1. Use of medications that could affect clinical assessment or cognitive test performance, including antipsychotic medications or continuous or therapy within the preceding month.
  2. Presence of additional neurological, psychiatric, or systemic diseases that could affect clinical or cognitive assessments.
  3. Participation in another structured exercise program.
  4. Experiencing an MS relapse within the preceding four weeks.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Tai Chi Intervention Group

    Participants received an 8-week Tai Chi intervention program designed for individuals with Multiple Sclerosis. The program included coordinated body movements, breathing control, and mindful movement practice, aiming to improve cognitive function, reduce fatigue, and improve depression levels in individuals with MS. The program consisted of progressively taught 8 movements selected from the basic 10 Yang-style forms, focusing on controlled weight shifting, postural alignment, and whole-body coordination. Each session consisted of a warm-up phase with general stretching exercises, a main Tai Chi practice component with form repetition and rest breaks as needed, and a cool-down phase including stretching and controlled breathing exercises.

    Other: Tai Chi Exercises Program

  • Active comparator
    Home Exercises Group

    Participants in this group received an 8-week home exercise program consisting of Frenkel coordination exercises. They were instructed to perform the prescribed exercises independently at home throughout the study period. Participants did not participate in the Tai Chi intervention. The program served as an active comparator for evaluating the effects of Tai Chi on cognitive function, fatigue, and depression in individuals with MS.

    Other: Frenkel Home Exercises

Interventions

  • OtherTai Chi Exercises Program

    Tai Chi was administered for 8 weeks, 2 days per week, for a total of 16 sessions. Each session lasted approximately 50 minutes and included warm-up stretching exercises (10 minutes), Tai Chi practice (30 minutes), and cool-down exercises (10 minutes). Sessions were conducted in groups of 2-3 participants under physiotherapist supervision.

  • OtherFrenkel Home Exercises

    Participants performed a home-based Frenkel exercise program for 8 weeks, twice weekly. Each session lasted approximately 15-30 minutes, excluding rest periods. Participants received an instructional booklet and an exercise logbook to record their exercise sessions. Adherence was monitored through telephone follow-up calls every two weeks.

06

What researchers measure

Primary outcomes

  1. Cognitive functions assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS)

    Cognitive functions were assessed using the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS), which includes the Symbol Digit Modalities Test (SDMT), California Verbal Learning Test-II (CVLT-II), and Brief Visuospatial Memory Test-Revised (BVMT-R).

    Time frame: Baseline and 8 weeks after the intervention

  2. Symbol Digit Modalities Test (SDMT)

    Information processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Higher scores indicate better cognitive performance

    Time frame: Baseline and 8 weeks after the intervention.

  3. California Verbal Learning Test-II (CVLT-II)

    Verbal learning and memory were assessed using the California Verbal Learning Test-II (CVLT-II). Higher scores indicate better verbal learning and memory performance.

    Time frame: Baseline and 8 weeks after the intervention.

  4. Brief Visuospatial Memory Test-Revised (BVMT-R)

    Visuospatial learning and memory were assessed using the Brief Visuospatial Memory Test-Revised (BVMT-R). Higher scores indicate better visuospatial learning and memory performance.

    Time frame: Baseline and 8 weeks after the intervention.

Secondary outcomes

  1. Fatigue Impact Scale (FIS) score

    The impact of fatigue on physical, cognitive, and social functioning was assessed using the Fatigue Impact Scale (FIS). Lower scores indicate less fatigue-related impact.

    Time frame: Baseline and 8 weeks after the intervention

  2. Beck Depression Inventory (BDI) score

    Depressive symptoms were assessed using the Beck Depression Inventory (BDI). Lower scores indicate fewer depressive symptoms.

    Time frame: Baseline and 8 weeks after the intervention

07

Study locations

1 site
  • Pamukkale University
    Denizli, Denizli 20000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07928557
Responsible party
Büşra ÇATALTAŞ (PHD,PT, Pamukkale University) — Principal investigator
First posted
Nov 10, 2026
Start date
Oct 2, 2023
Primary completion
Feb 28, 2025
Completion
Feb 28, 2025
Last update
Nov 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion